ROADMAP STUDY DEMONSTRATING BENEFITS OF HEARTMATE II® LEFT VENTRICULAR ASSIST DEVICE PRESENTED AT ISHLT CONFERENCE
NICE, FR April, 17, 2015 – Today at the 35th Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting & Scientific Sessions , researchers presented one-year results from the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients). The study evaluated the effects of Thoratec Corporation’s (NASDAQ: THOR) HeartMate II® Left Ventricular Assist Device (LVAD) compared with optimal medical management patients. Results from the